The Cancer Institute At Alexian Brothers — Elk Grove Village, Illinois

The Cancer Institute At Alexian Brothers is a clinical research site located in Elk Grove Village, Illinois, United States 60007.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

The Cancer Institute At Alexian Brothers has participated in 3 clinical trials.

Therapeutic areas: Chronic Phase Chronic Myeloid Leukemia, Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant.

Sponsors: Bristol-Myers Squibb, Novartis Pharmaceuticals, Synta Pharmaceuticals Corp..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Elk Grove Village

Browse all research sites in Illinois · View every site in Elk Grove Village

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Cancer Institute At Alexian Brothers?

The Cancer Institute At Alexian Brothers has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Cancer Institute At Alexian Brothers conducted?

The Cancer Institute At Alexian Brothers has 3 clinical trials on record. Their work covers Chronic Phase Chronic Myeloid Leukemia, Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant.

Is The Cancer Institute At Alexian Brothers accredited by Crixeo Clinical Trials?

The Cancer Institute At Alexian Brothers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Cancer Institute At Alexian Brothers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.